Carisma Therapeutics Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
CARM on Nasdaq
Industry
Pharmaceutical Preparations
Location
3675 Market Street, Suite 200, Philadelphia, PA

There are no Buy or Sell transactions made by insiders since 9/13/2023

Carisma Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Hohneker Director Jun 26, 2024
David Scadden Director Jul 1, 2024
Marella Thorell Director Jul 1, 2024
Sanford Zweifach Director Jun 26, 2024
Steven Kelly President and CEO, Director Jun 17, 2024
Briggs Morrison Director Jun 26, 2024
Richard Morris Chief Financial Officer Jun 17, 2024
Bjorn Odlander Director Mar 7, 2023
Michael Torok Director Jun 26, 2024
Michael Klichinsky Chief Scientific Officer Jun 17, 2024
Regina Hodits Director Mar 7, 2023
Chidozie Ugwumba Director Jun 6, 2023
ModernaTX, Inc. 10%+ Owner Mar 7, 2023
Peter Honig Director Jun 22, 2022
Elly Ryu Principal Accounting Officer Mar 2, 2023
A. Jewett Michael Director Jun 22, 2022
Minori Rosales Chief Development Officer Jan 24, 2022
Jay S. Duker Director Jun 22, 2022
Glen C. MacDonald Chief Technology Officer Mar 2, 2023
Mark Sullivan General Counsel & Secretary Mar 2, 2023
Monica Forbes Chief Financial Officer Mar 2, 2023
Thomas R. Cannell President and CEO, Director Mar 2, 2023
Jane Henderson Director May 3, 2021
Carrie L. Bourdow Director Jun 22, 2022
Patricia M. Drake Chief Commercial Officer Jun 1, 2021
Jason A. Keyes Director Jun 22, 2022

Recent Insider Transactions by Companies or Individuals for Carisma Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.